Browse Guides  internal medicine  cardiology

Myocardial infarction

Prevalence
Clinical features
Differential diagnosis
Investigations
Therapy
Prevention
Prognosis
Prevention

Diet

Avoid giving beta-carotene a

Why?

  • It increases mortality, despite reducing non-fatal myocardial infarction. a

Beta-carotene reduces non-fatal MI but increases mortality

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
myocardial infarction a beta-carotene placebo death
at 6 years
13% 33%
(1% to 54%)
24
(12 to 1200)
      non-fatal MI
at 6 years
8.9% -80%
(-160% to -25%)
-14
(-35 to -9)

 

 

Expiry date: November 2003
Levels of Evidence used in grading these guides

Author   CM   Ball , N   Shenker
Reviewer   S   Straus
CAT Writers   CJ   Wotton , N   Shenker , B   Phillips , CM   Ball